SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers



Status:Completed
Conditions:Smoking Cessation, Tobacco Consumers
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 99
Updated:2/16/2018
Start Date:April 2013
End Date:December 31, 2017

Use our guide to learn which trials are right for you!

The purpose of this study is to examine the implementation of two evidence-based intervention
strategies of SBIRT (Generalist vs. Specialist) for adolescent alcohol, tobacco, other drug
use, and HIV risk behaviors.

Guided by Proctor's conceptual model of implementation research, the proposed study is a
multi-site, cluster randomized trial to compare two principal strategies of SBIRT delivery
within adolescent medicine. In the Generalist Strategy, the primary care provider delivers
brief intervention (BI) for substance misuse. In the Specialist Strategy, BIs are delivered
by behavioral health counselors. The 7 study sites, primary care clinics operated by a large,
urban Federally Qualified Health Center in Baltimore, will be randomly assigned to implement
SBIRT for adolescents using either the Generalist or Specialist strategies. Staff at each
site will be trained in the assigned implementation strategy, and quarterly booster trainings
will be provided during the implementation period. Implementation outcomes, including:
penetration, costs/cost-effectiveness, acceptability, timeliness, fidelity/adherence, and
patient satisfaction will be assessed during the 18-month-long implementation period using a
complementary combination of administrative service encounter data, provider and patient
surveys, and qualitative interviews. At the end of the active implementation period, all
training and technical support activities will cease for 12 months in order to measure
relative sustainability. The study will also examine the effectiveness of integrating HIV
risk screening within an SBIRT model.

Inclusion Criteria:

- clinic staff

Exclusion Criteria:
We found this trial at
1
site
Baltimore, Maryland 21217
Principal Investigator: Arethusa S Kirk, MD
Phone: 410-383-8300
?
mi
from
Baltimore, MD
Click here to add this to my saved trials